Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis
出版年份 2015 全文链接
标题
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis
作者
关键词
-
出版物
Therapeutic Advances in Neurological Disorders
Volume 9, Issue 1, Pages 9-30
出版商
SAGE Publications
发表日期
2015-11-07
DOI
10.1177/1756285615612659
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Drug-resistant MS spasticity treatment with Sativex®add-on and driving ability
- (2014) M. Freidel et al. ACTA NEUROLOGICA SCANDINAVICA
- Delta-9-Tetrahydrocannabinol/Cannabidiol (Sativex®): A Review of Its Use in Patients with Moderate to Severe Spasticity Due to Multiple Sclerosis
- (2014) Yahiya Y. Syed et al. DRUGS
- A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment
- (2014) M. Serpell et al. EUROPEAN JOURNAL OF PAIN
- Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice
- (2014) Peter Flachenecker et al. EUROPEAN NEUROLOGY
- Advances in the Management of MS Spasticity: Recent Observational Studies
- (2014) Oscar Fernández EUROPEAN NEUROLOGY
- Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity
- (2014) Peter Flachenecker et al. EUROPEAN NEUROLOGY
- Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis
- (2014) Irene Moreno Torres et al. Expert Review of Neurotherapeutics
- Linguistic and psychometric validation of the MSSS-88 questionnaire for patients with multiple sclerosis and spasticity in Germany
- (2014) Thomas Henze et al. Health and Quality of Life Outcomes
- Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity
- (2014) Jürgen Koehler et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity
- (2014) P. Browne et al. NEUROLOGY
- Impact of Sativex®on quality of life and activities of daily living in patients with multiple sclerosis spasticity
- (2014) Rafael Arroyo et al. Journal of Comparative Effectiveness Research
- Spasticity in patients with multiple sclerosis - clinical characteristics, treatment and quality of life
- (2013) P. Flachenecker et al. ACTA NEUROLOGICA SCANDINAVICA
- Costs and quality of life in multiple sclerosis patients with spasticity
- (2013) J. Svensson et al. ACTA NEUROLOGICA SCANDINAVICA
- Driving performance in persons with mild to moderate symptoms of multiple sclerosis
- (2013) Hannes Devos et al. DISABILITY AND REHABILITATION
- Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain
- (2013) Antonio García-Merino Expert Review of Neurotherapeutics
- A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost–effectiveness in Germany
- (2013) Peter Flachenecker Expert Review of Neurotherapeutics
- Spasticity in multiple sclerosis: results of a patient survey
- (2013) C. Oreja-Guevara et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Cerebral palsy
- (2013) Allan Colver et al. LANCET
- A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers
- (2013) Colin Stott et al. SpringerPlus
- A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray
- (2012) C. G. Stott et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- A phase I study to assess the single and multiple dose pharmacokinetics of THC/CBD oromucosal spray
- (2012) C. G. Stott et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Troublesome Symptoms in Cancer Survivors: Fatigue, Insomnia, Neuropathy, and Pain
- (2012) Deirdre R. Pachman et al. JOURNAL OF CLINICAL ONCOLOGY
- The Unique Features of Traumatic Brain Injury in Children. Review of the Characteristics of the Pediatric Skull and Brain, Mechanisms of Trauma, Patterns of Injury, Complications and Their Imaging Findings-Part 1
- (2012) Pedro S. Pinto et al. JOURNAL OF NEUROIMAGING
- Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis
- (2012) Michael G. Serpell et al. JOURNAL OF NEUROLOGY
- Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial
- (2012) Russell K. Portenoy et al. JOURNAL OF PAIN
- An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics
- (2012) Jeremy R. Johnson et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Sativex® in multiple sclerosis spasticity: a cost–effectiveness model
- (2012) John Slof et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity
- (2012) Verena Isabell Leussink et al. Therapeutic Advances in Neurological Disorders
- Immune-mediated CNS diseases: A review on nosological classification and clinical features
- (2011) Uwe K. Zettl et al. AUTOIMMUNITY REVIEWS
- A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
- (2011) A. Novotna et al. EUROPEAN JOURNAL OF NEUROLOGY
- Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine
- (2011) Philip Robson Expert Opinion On Drug Safety
- THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis
- (2011) Jaume Sastre-Garriga et al. Expert Review of Neurotherapeutics
- A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)
- (2011) W Notcutt et al. Multiple Sclerosis Journal
- Contribution of impaired mobility and general symptoms to the burden of multiple sclerosis
- (2010) Howard L. Zwibel ADVANCES IN THERAPY
- Plasma Cannabinoid Pharmacokinetics following Controlled Oral 9-Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration
- (2010) E. L. Karschner et al. CLINICAL CHEMISTRY
- Rehabilitation in practice: Spasticity management
- (2010) VL Stevenson CLINICAL REHABILITATION
- Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis
- (2010) Derick T Wade et al. Multiple Sclerosis Journal
- A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
- (2010) C. Collin et al. NEUROLOGICAL RESEARCH
- Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic pain
- (2010) David J. Hewitt et al. PAIN
- Emerging strategies for exploiting cannabinoid receptor agonists as medicines
- (2009) Roger G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- National MS registries
- (2009) Peter Flachenecker et al. JOURNAL OF NEUROLOGY
- Stop using the Ashworth scale for the assessment of spasticity
- (2009) K. S Sunnerhagen JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Stop using the Ashworth Scale for the assessment of spasticity
- (2009) J F M Fleuren et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain
- (2009) Jeremy R. Johnson et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- (2009) Angelo A. Izzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The Contribution of Cognition and Spasticity to Driving Performance in Multiple Sclerosis
- (2008) Thomas D. Marcotte et al. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
- Validity, reliability, and clinical importance of change in a 0—10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial
- (2008) John T. Farrar et al. CLINICAL THERAPEUTICS
- Managing neuropathic pain with Sativex®: a review of its pros and cons
- (2008) Jordi Perez et al. EXPERT OPINION ON PHARMACOTHERAPY
- Control of Spasticity in a Multiple Sclerosis Model is mediated by CB1, not CB2, Cannabinoid Receptors
- (2007) G Pryce et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid pharmacology: the first 66 years
- (2006) Roger G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started